Synendos Therapeutics (private company)

See something wrong or missing? Let us know
Offices:Basel
Business model:B2B

Synendos is a Swiss biotech company developing first-in-class inhibitors that modulate a newly identified drug target in the body’s endocannabinoid system, enabling restoration of endogenous cannabinoid levels that are suppressed in certain pathological conditions.

Investors: we tracked 8 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 21.91M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Synendos Therapeutics

Name Criteria
Denmark Draupnir Bio
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: High-Tech Gründerfonds
  • Total raised in a similar range: 10M+ USD
Denmark Galecto Biotech
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Spain Medlumics
63%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Kurma Life Science Partners
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Finland Synoste Oy
63%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: High-Tech Gründerfonds
  • Total raised in a similar range: 10M+ USD
Germany Tubulis
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: High-Tech Gründerfonds
  • Total raised in a similar range: 10M+ USD
Italy Wise Srl
63%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: High-Tech Gründerfonds
  • Total raised in a similar range: 10M+ USD
Germany Egym
63%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: High-Tech Gründerfonds
  • Total raised in a similar range: 10M+ USD
Switzerland Memo Therapeutics
58%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: Bernina BioInvest, Zürcher Kantonalbank, Schroder Adveq
  • Total raised in a similar range: 10M+ USD
Top